SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company with clinical development programs focusing on organ ...
vTv Therapeutics resumes Phase 3 trial of cadisegliatin for type 1 diabetes, shortening duration to 6 months for faster results. vTv Therapeutics Inc. has reinitiated screening in its CATT1 Phase 3 ...
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
SAINT PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in ...
Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to Phase III VIKTORIA-1 Additional Results ...
Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...
MELBOURNE, Australia, Dec. 15, 2025 /PRNewswire/ -- Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announces that the ACTION3 Phase 3 ...
aTyr Pharma is a small-cap biotech focused on Efzofitimod for interstitial lung disease (ILD), a group of lung-scarring diseases. In 2021, the company completed a phase 1b/2a trial in pulmonary ...
A new single-shot combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a phase 3 clinical trial published May 7 in JAMA. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback